These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 22948889)

  • 21. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
    Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
    Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging era of pharmacogenomics: current successes, future potential, and challenges.
    Lee JW; Aminkeng F; Bhavsar AP; Shaw K; Carleton BC; Hayden MR; Ross CJ
    Clin Genet; 2014 Jul; 86(1):21-8. PubMed ID: 24684508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics: past, present and future.
    Pirmohamed M
    Drug Discov Today; 2011 Oct; 16(19-20):852-61. PubMed ID: 21884816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomics for Drug Dosing in Children: Current Use, Knowledge, and Gaps.
    Hoshitsuki K; Fernandez CA; Yang JJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S188-S192. PubMed ID: 34185912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics discovery and implementation in genome-wide association studies era.
    Ni X; Zhang W; Huang RS
    Wiley Interdiscip Rev Syst Biol Med; 2013; 5(1):1-9. PubMed ID: 23188748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
    Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
    Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
    Lesko LJ; Zineh I
    Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics: Precision Medicine and Drug Response.
    Weinshilboum RM; Wang L
    Mayo Clin Proc; 2017 Nov; 92(11):1711-1722. PubMed ID: 29101939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomics and personalized medicine in clinical practice.
    Manolopoulos VG; Dechairo B; Huriez A; Kühn A; Llerena A; van Schaik RH; Yeo KT; Ragia G; Siest G
    Pharmacogenomics; 2011 May; 12(5):597-610. PubMed ID: 21619425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
    Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
    [No Abstract]   [Full Text] [Related]  

  • 33. Gene-Based Dose Optimization in Children.
    Ramsey LB; Brown JT; Vear SI; Bishop JR; Van Driest SL
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():311-331. PubMed ID: 31283429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.
    Lazaridis KN
    Clin Pharmacol Ther; 2017 Jan; 101(1):39-41. PubMed ID: 27804107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential Characteristics of Pharmacogenomics Study Publications.
    Thorn CF; Whirl-Carrillo M; Hachad H; Johnson JA; McDonagh EM; Ratain MJ; Relling MV; Scott SA; Altman RB; Klein TE
    Clin Pharmacol Ther; 2019 Jan; 105(1):86-91. PubMed ID: 30406943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
    Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
    OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
    Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
    Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomic Determinants of Interindividual Drug Response Variability: From Discovery to Implementation.
    Scott SA; Swen JJ
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33801919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system.
    Dunnenberger HM; Biszewski M; Bell GC; Sereika A; May H; Johnson SG; Hulick PJ; Khandekar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1956-1966. PubMed ID: 27864203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience.
    Aquilante CL; Kao DP; Trinkley KE; Lin CT; Crooks KR; Hearst EC; Hess SJ; Kudron EL; Lee YM; Liko I; Lowery J; Mathias RA; Monte AA; Rafaels N; Rioth MJ; Roberts ER; Taylor MR; Williamson C; Barnes KC
    Pharmacogenomics; 2020 Apr; 21(6):375-386. PubMed ID: 32077359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.